OncoImmunity

Business Services · Norway · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Ullernchausséen 64, Oslo, Oslo, 0379, No...

Phone Number

+47 90015242

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About OncoImmunity

NEC Bio B.V. is dedicated to developing innovative therapies for patients worldwide, utilizing advanced AI technologies. The company focuses on personalized cancer vaccines and next-generation vaccines for infectious diseases, employing strategies that target specific tumor antigens and immunogenic pathogens. Their research includes collaborations with various partners to enhance cancer immunotherapy and vaccine development. NEC Bio's pipeline features proprietary technologies aimed at improving patient outcomes in oncology and infectious disease treatment.Explore more
OncoImmunity's Social MediaPopular SearchesOncoImmunityNEC OncoImmunity AsOncoImmunity AsSIC Code 87,873NAICS Code 54,541Show more

Is OncoImmunity your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

OncoImmunity is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

OncoImmunity is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoImmunity.

OncoImmunity Tech Stack

A closer look at the technologies used by OncoImmunity

Top Business Services Companies

Frequently Asked Questions Regarding OncoImmunity

What is OncoImmunity's official website?
OncoImmunity's official website is www.oncoimmunity.com
What is OncoImmunity's Revenue?
OncoImmunity's revenue is <$5 Million
What is OncoImmunity's SIC code?
OncoImmunity's SIC: 87,873
What is OncoImmunity's NAICS code?
OncoImmunity's NAICS: 54,541
How many employees does OncoImmunity have?
OncoImmunity has 11-50 employees
What industry does OncoImmunity belong to?
OncoImmunity is in the industry of: Business Services, Research & Development
What companies has OncoImmunity acquired?
OncoImmunity has acquired the companies: Sphere Communications, Vibren Technologies, Accelent Systems, CSG Systems
What technology does OncoImmunity use?
Some of the popular technologies that OncoImmunity uses are: reCAPTCHA, Google Universal Analytics, Google Cloud Platform, Unix
How do I contact OncoImmunity?
OncoImmunity contact info: Phone number: +47 90015242 Website: www.oncoimmunity.com
What does OncoImmunity do?

NEC Bio B.V. is dedicated to developing innovative therapies for patients worldwide, utilizing advanced AI technologies. The company focuses on personalized cancer vaccines and next-generation vaccines for infectious diseases, employing strategies that target specific tumor antigens and immunogenic pathogens. Their research includes collaborations... with various partners to enhance cancer immunotherapy and vaccine development. NEC Bio's pipeline features proprietary technologies aimed at improving patient outcomes in oncology and infectious disease treatment.Read More

What are OncoImmunity social media links?
OncoImmunity Linkedin page OncoImmunity Twitter page OncoImmunity Facebook page
Is OncoImmunity a public company?
OncoImmunity is private company therefore does not currently have an official ticker symbol
See more information about OncoImmunity

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.